Evaluating the Associations Among Dysautonomia, Gastrointestinal Transit, and Clinical Phenotype in Patients With Systemic Sclerosis
Symptoms of global dysautonomia are seen in up to one-third of patients with SSc and GI involvement. Identifying specific clinical characteristics associated with GAD in SSc will help to identify a population that may benefit from therapies that modulate the autonomic nervous system.
Authors
- Michael Hughes (ORCID: https://orcid.org/0000-0003-3361-4909)
- Zsuzsanna H. McMahan (ORCID: https://orcid.org/0000-0001-6461-8940)
- Brittany L. Adler (ORCID: https://orcid.org/0000-0001-9912-2435)
- Jamie Perin (ORCID: https://orcid.org/0000-0002-5482-6620)
- María Paula Álvarez-Hernández (ORCID: https://orcid.org/0000-0002-9972-1312)
Institutions
- Johns Hopkins University (US)
- Salford Royal NHS Foundation Trust (GB)
- University of Manchester (GB)
- Hospital Universitario de La Princesa (ES)
- University of Salford (GB)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1002/acr.25411
- Citations
- 7
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.97
Funders
- Johns Hopkins University
- National Institutes of Health
- Johns Hopkins Bloomberg School of Public Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases